A conflict of interest affecting global litigation giant Howrey isn’t serious enough to warrant the firm’s disqualification from a major drug patent case, a federal judge in New Jersey said Tuesday.

U.S. District Judge Joel Pisano reversed a magistrate judge’s decision that 650-lawyer Howrey is automatically prohibited from defending Boston Scientific Corp. against a suit by Wyeth in Newark, N.J., because the firm represents Wyeth in a patent case in Europe.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]